IN BRIEF: Destiny Pharma raises GBP450,000 through open offer

Destiny Pharma PLC - a clinical-stage biotechnology company based in Brighton, England - Raises ...

Alliance News 25 March, 2022 | 2:26PM
Email Form Facebook Twitter LinkedIn RSS

Destiny Pharma PLC - a clinical-stage biotechnology company based in Brighton, England - Raises total gross proceeds of GBP450,000 through its open offer. Has conditionally raised total gross proceeds of GBP6.5 million through its placing, subscription, and open offer. Says it has applied for the admission of 12.9 million shares, consisting of 11.9 million placing shares, 140,000 subscription shares and 909,007 open offer shares.

Destiny Pharma said earlier this month that it intends to raise GBP7.0 million through a placing of 11.9 million shares at 50 pence each, a subscription for 140,000 shares and an open offer for 2.0 million shares.

Current stock price: 50.67 pence

12-month change: down 65%

By Abby Amoakuh; abbyamoakuh@alliancenews.com

Copyright 2022 Alliance News Limited. All Rights Reserved.

Email Form Facebook Twitter LinkedIn RSS

Securities Mentioned in Article

Security Name Price Change (%) Morningstar
Rating
Destiny Pharma PLC

About Author

Alliance News

Alliance News provides Morningstar with continuously updating coverage of news affecting listed companies.

© Copyright 2024 Morningstar, Inc. All rights reserved.

Terms of Use        Privacy Policy        Modern Slavery Statement        Cookie Settings        Disclosures